At the time of writing, Procept BioRobotics Corp [PRCT] stock is trading at $32.27, up 7.53%. It is a good measure of the stock’s recent performance to check whether the stock’s short-term value is rising or falling. The PRCT shares have gain 13.63% over the last week, with a monthly amount drifted -11.22%, and not seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Procept BioRobotics Corp [NASDAQ: PRCT] stock has seen the most recent analyst activity on September 02, 2025, when Oppenheimer upgraded its rating to an Outperform but kept the price target unchanged to $60 for it. Previously, Stephens started tracking the stock with Overweight rating on July 09, 2025, and set its price target to $70. On July 07, 2025, Oppenheimer initiated with a Perform rating. Morgan Stanley started tracking the stock assigning an Overweight rating and suggested a price target of $105 on December 02, 2024. Jefferies initiated its recommendation with a Hold and recommended $95 as its price target on November 14, 2024. Piper Sandler started tracking with an Overweight rating for this stock on August 11, 2023, and assigned it a price target of $42. In a note dated May 31, 2023, William Blair initiated an Outperform rating.
For the past year, the stock price of Procept BioRobotics Corp fluctuated between $27.80 and $100.89. Currently, Wall Street analysts expect the stock to reach $53.2 within the next 12 months. Procept BioRobotics Corp [NASDAQ: PRCT] shares were valued at $32.27 at the most recent close of the market. An investor can expect a potential return of 64.86% based on the average PRCT price forecast.
Analyzing the PRCT fundamentals
According to Procept BioRobotics Corp [NASDAQ:PRCT], the company’s sales were 299.91M for trailing twelve months, which represents an 42.76% jump. Gross Profit Margin for this corporation currently stands at 0.65% with Operating Profit Margin at -0.31%, Pretax Profit Margin comes in at -0.28%, and Net Profit Margin reading is -0.28%. To continue investigating profitability, this company’s Return on Assets is posted at -0.17, Equity is -0.22 and Total Capital is -0.2. Upon thorough examination of the company’s fundamental financial framework, it becomes apparent that the debt-to-equity ratio stands at 0.21.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 30.61 points at the first support level, and at 28.94 for the second support level. However, for the 1st resistance point, the stock is sitting at 33.36, and for the 2nd resistance point, it is at 34.44.
Ratios To Look Out For
It is important to note that Procept BioRobotics Corp [NASDAQ:PRCT] has a current ratio of 8.43. Further, the Quick Ratio stands at 7.19, while the Cash Ratio is 5.46. Considering the valuation of this stock, the price to sales ratio is 6.01, the price to book ratio is 4.74.
Transactions by insiders
Recent insider trading involved MOLL FREDERIC H, Director, that happened on Aug 13 ’25 when 20000.0 shares were purchased. Director, Desai Antal Rohit completed a deal on Jun 10 ’25 to sell 25000.0 shares. Meanwhile, Director Desai Antal Rohit sold 25000.0 shares on Jun 11 ’25.
